Nadine Besson is Founder & President of BioLiterate, a nonprofit dedicated to advancing AI literacy across the biomedical community. She brings over 15 years of global biopharma experience to the conversation, having held strategic partnering and commercial insights leadership roles at global organizations including Pfizer, Roche/Genentech, and Gilead. In her current role as Director of Commercial Analytics and Insights at BridgeBio, she works at the intersection of data science, launch strategy, and business operations. Through BioLiterate, she champions AI fluency not just within industry, but for the patient communities that AI in healthcare is ultimately meant to serve — bringing a dual perspective as both a biopharma operator and a patient-advocacy voice to conversations on responsible AI adoption in drug development and patient care. Nadine holds dual Master's degrees from ESCP Business School and Université Paris Diderot, along with certifications in Pharmacology and AI in Biomedicine from Harvard Medical School. She is based between San Francisco and Europe.